「疾っくに」に関連した英語例文の一覧と使い方(116ページ目) - Weblio英語例文検索

３　健康保険法等の規定による被保険者又は組合員である被認定者が、当該認定に係る指定疾病について保険医療機関等から医療を受ける場合には、健康保険法等の規定により当該保険医療機関等に支払うべき一部負担金は、健康保険法等の規定にかかわらず、当該医療に関し機構が第一項の規定による支払をしない旨の決定をするまでは、支払うことを要しない。例文帳に追加

(3) In the event that an insured person or a partner pursuant to the provisions of the Health Insurance Act, etc., as a certified person, receives a medical services from an authorized insurance medical institution, etc. for the designated disease to which the said certification pertains, the partial charge to be paid to the said authorized insurance medical institution, etc. pursuant to the provisions of the Health Insurance Act, etc. shall not be required to be paid irrespective of the provisions of the Health Insurance Act, etc., until the Agency determines to the effect that the Agency will not make the payment pursuant to Particle 1 for the said medical service.  - 日本法令外国語訳データベースシステム

第二十四条　市町村は、保護者の労働又は疾病その他の政令で定める基準に従い条例で定める事由により、その監護すべき乳児、幼児又は第三十九条第二項に規定する児童の保育に欠けるところがある場合において、保護者から申込みがあつたときは、それらの児童を保育所において保育しなければならない。ただし、付近に保育所がない等やむを得ない事由があるときは、その他の適切な保護をしなければならない。例文帳に追加

Article 24 (1) In the case where a guardian' working or illness or any other reasons prescribed by a Municipal Ordinance in accordance with the standards specified by a Cabinet Order causes lack in daycare of an infant, a toddler or a child prescribed in Article 39 paragraph (2) whose custody must be taken by the guardian, a municipal government shall, when the guardian applies, provide daycare to those children in a nursery center; provided, however, that other adequate aid shall be provided when there is any unavoidable reason such as non-existence of an adjacent nursery center.  - 日本法令外国語訳データベースシステム

任意の対象化合物を生物材料又は動物に投与することにより量的変動及び／又は時間的変動が確認できた観測分子の変動を、前記生物材料及び前記動物そのものの解析を行うことなく、生体分子と生体イベントとの関係の情報を含む生体分子ネットワークを用いて解析することにより、該対象化合物の標的分子が関わる生物学的機能及び／又は疾患を推定する。例文帳に追加

This method intends to analyze quantitative variation and/or time variation of the observed molecule verified by administering an optional target compound to biological material or animal, without analyzing the above biological material or animal itself, through use of biomolecule network including information on relation between biomolecule and biological event, presuming biological functions and/or disease in which the target molecule of the above target compound may involve. - 特許庁

その多くの実施形態において、本発明は、サイクリン依存性キナーゼのインヒビターとしてのピラゾロ［１，５−ａ］ピリミジン化合物の新規クラス、このような化合物の調製方法、１種以上のこのような化合物を含有する薬学的組成物、１種以上のこのような化合物を含有する薬学的処方物の調製方法、および、このような化合物または薬学的組成物を使用して、ＣＤＫに関連する１種以上の疾患を処置、予防、防止または緩和する方法を提供する。例文帳に追加

In its many embodiments, there are provided a new class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions. - 特許庁

このため、全ての肝炎患者等が継続的かつ適切な肝炎医療を受けることができる体制を整備するため、拠点病院を中心として、「都道府県における肝炎検査後肝疾患診療体制に関するガイドライン」（平成19年全国C型肝炎診療懇談会報告書）に基づき、拠点病院、専門医療機関及びかかりつけ医が協働する仕組みとして、地域における肝炎診療ネットワークの構築を進める必要がある。例文帳に追加

Therefore, it is necessary for core centers to develop a regional network for hepatitis treatment, where core centers, specialized institutions and primary physicians cooperate with each other in accordance with the "Guidelines for the system for treatment of liver disease after hepatitis test in local regions" (Report of National Conference of Hepatitis C in 2007), to develop a system that ensures all patients with hepatitis receive appropriate and continuous treatment. - 厚生労働省

２　前項の許可を受けようとする者は、農林水産省令で定めるところにより、当該水産動物の種類及び数量、原産地、輸入の時期及び場所その他農林水産省令で定める事項を記載した申請書に、輸出国の政府機関により発行され、かつ、その検査の結果当該水産動物が輸入防疫対象疾病にかかつているおそれがないことを確かめ、又は信ずる旨を記載した検査証明書又はその写しを添えて、これを農林水産大臣に提出しなければならない。例文帳に追加

(2) Any person who intends to obtain the permission set forth in the preceding paragraph shall submit, as provided for in the Ordinance of the Ministry of Agriculture, Forestry and Fisheries, a written application in which the kind and quantity, origin, time and place of import of such aquatic animals and other items provided for in the Ordinance of the Ministry of Agriculture, Forestry and Fisheries are described to the Minister of Agriculture, Forestry and Fisheries with an inspection certificate issued by the governmental organization of the exporting country in which the content is described, or its copy attached to the effect that it is confirmed or believed that the aquatic animals in question are not infected with a disease or diseases subject to import quarantine as a result of inspection conducted by such organization.  - 日本法令外国語訳データベースシステム

１つの実施形態において、本発明は、ＭＣＨレセプターのアンタゴニストとして新規なクラス（Ｉ）の化合物、このような化合物を調製する方法、１つ以上のこのような化合物を含有する薬学的組成物、１つ以上のこのような化合物を含有する薬学的処方物を調製する方法、ならびにＭＣＨレセプターに関連した１つ以上の疾患の処置、予防または改善の方法を提供し、ここで、Ａｒ^１は、以下の部分（ＩＩ）から選択される。例文帳に追加

In one embodiment, the invention provides a new class (I) of compounds as antagonists of the MCH receptor; methods of preparing such compounds; pharmaceutical compositions containing at least one of the compounds; methods of preparing pharmaceutical formulations containing at least one of the compounds; and methods of treating, preventing or ameliorating at least one of diseases associated with the MCH receptor. - 特許庁

第十三条　被認定者が、石綿健康被害医療手帳を提示して、当該認定に係る指定疾病について、保険医療機関等から医療を受けた場合においては、機構は、医療費として当該被認定者に支給すべき額の限度において、その者が当該医療に関し当該保険医療機関等に支払うべき費用を、当該被認定者に代わり、当該保険医療機関等に支払うことができる。例文帳に追加

Article 13 (1) In the event that a certified person has received a medical service from an authorized insurance medical institution, etc. for the designated disease to which the said certification pertains after having presented his/her Asbestos Health Damage Medical Passbook, the Agency may pay the expenses to be paid by the certified person for the said medical services to the said authorized insurance medical institution, etc. in lieu of the said certified person, to the extent of the amount to be paid for the said certified person as medical expenses.  - 日本法令外国語訳データベースシステム

本発明は、その多くの実施形態において、サイクリン依存性キナーゼのインヒビターとしての新規クラスのピラゾール［１，５−α］ピリミジン化合物、このような化合物を調製する方法、このような化合物を一種以上含有する薬学的組成物を調製する方法、およびこのような化合物または薬学的組成物を使用してＣＤＫと関連する一種以上の疾患を処置するか、予防するか、阻害するか、または回復する方法を提供する。例文帳に追加

The invention, in its many embodiments, provides a new class of pyrazolo[1,5-α]pyrimidine compounds as inhibitors of cyclin-dependent kinases, methods of preparing such compounds, methods of preparing pharmaceutical compositions containing one or more such compounds, methods of treating, preventing, inhibiting, or ameliorating one or more diseases associated with the CDKs (cyclin-dependent kinases) using such compounds or pharmaceutical compositions. - 特許庁

ヒト腫瘍壊死因子−α（ＴＮＦα）に特異的であり、かつＴＮＦに仲介される種々の疾患や症状のｉｎ ｖｉｖｏでの診断および治療に有用な抗ＴＮＦ抗体、そのフラグメントおよび領域部分、並びに、マウスとのキメラ抗体をコードするポリヌクレオチド、前記抗体の製造方法、並びに前記抗ＴＮＦ抗体、そのフラグメント、領域およびそれらの誘導体の免疫学的分析や免疫学的治療への応用に関する種々のアプローチを提供する。例文帳に追加

The invention provides: an anti-TNF antibody, fragment and region thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo for diagnosis and therapy of various TNFα-mediated diseases and symptoms; a polynucleotide encoding a murine and chimeric antibody; methods for producing the antibody; and various approaches of the anti-TNF antibody, fragment, region and derivative thereof for the applications to immunoassays and immunological therapy. - 特許庁

なお、児童扶養手当の受給開始から5年を経過した者等に対する一部支給停止措置については、与党のプロジェクトチームにおいて、受給者本人やその子ども等の障害・疾病等により就業が困難な事情がないにもかかわらず、就業意欲がみられない者についてのみ支給額の2分の1を支給停止することとし、それ以外の者については一部支給停止を行わないこととする旨の取りまとめがなされた。例文帳に追加

The ruling parties’ project team has been discussing the current policy of partially stopping payment of the Child Rearing Allowance to the recipients who have received it for 5 years. The team concluded that allowance payment should be reduced to half for only those recipients who are apparently not willing to work with no justifiable reason for not working (e.g., disabilities or disease of the recipient or her child) and that other recipients should be allowed to continue to receive the allowance. - 厚生労働省

第三十八条の四　常時百人以上の労働者を使用する事業場において業務上負傷し、又は疾病にかかつた労働者と同一職種の同一条件の労働者がいない場合における当該労働者の休業補償の額の改訂は、当該事業場の全労働者に対して所定労働時間労働した場合に支払われる通常の賃金の四半期ごとの平均給与額が上昇し又は低下した場合に行うものとする。例文帳に追加

Article 38-4 If there exists no worker whose job and working conditions are the same as those of a worker who has been injured or gotten ill on the job in a workplace which usually employs 100 workers or more, the amount of the compensation for absence from work paid to the worker shall be adjusted when the quarterly average of the ordinary wages paid to all the workers in a workplace for the prescribed working hours is increased or decreased.  - 日本法令外国語訳データベースシステム

TSH受容体への免疫反応に付随する自己免疫疾患の診断または治療に使用するために、TSH受容体に応答して産生した自己抗体および／またはリンパ球が(TSH受容体とこの自己抗体またはリンパ球との相互作用が可能になる条件下で適切に)相互作用する１以上のTSH受容体抗原決定基の１次構造配座(アミノ酸残基の連続的な配列)の部分または全部を含むペプチド配列。例文帳に追加

Disclosed is a peptide sequence comprising a part or all of primary structural conformation (continuous sequences of amino acid residues) of one or more epitopes of TSH receptors, wherein autoantibodies and/or lymphocytes produced in response to the TSH receptor suitably interact under a condition in which a TSH receptor can interact with autoantibodies thereof or lymphocytes to use for diagnosis or treatment of autoimmune diseases accompanying immune reaction to a TSH receptor. - 特許庁

チロシンキナーゼ阻害作用、特に、Ｓｙｋキナーゼ阻害作用に優れるチエノピリミジンジアミン誘導体、その薬理上許容される塩、その薬理上許容される水和物、その薬理上許容される溶媒和物、その薬理上許容されるプロドラッグ、これらの製法、及び、Ｓｙｋキナーゼ関連疾患の予防及び／又は治療に優れる、上記チエノピリミジンジアミン誘導体を有効成分として含有する医薬組成物を提供する。例文帳に追加

To provide a thienopyrimidine diamine derivative, a pharmacologically acceptable salt thereof, a pharmacologically acceptable hydrate thereof, a pharmacologically acceptable solvate thereof and a pharmacologically acceptable prodrug thereof that are excellent in tyrosine kinase-inhibiting actions, particularly in Syk kinase-inhibiting actions, a manufacturing method thereof, and a pharmaceutical composition comprising as an effective ingredient the thienopyrimidine diamine derivative that is excellent in prevention and/or treatment of Syk kinase-related diseases. - 特許庁

安全かつ経口投与で高い効力を有するミトコンドリア病、特に慢性進行性外眼筋麻痺症候群（ＣＰＥＯ）、ＭＥＲＲＦ（赤色ぼろ線維を持つミトコンドリア異常を伴うミオクローヌスてんかん）、ＭＥＬＡＳ（ミトコンドリア筋症脳症高乳酸血症、脳卒中様症状）、ミトコンドリア遺伝子変異による糖尿病、心筋症、アルツハイマー痴呆症、聴覚障害、網膜変性疾患等の予防又は治療薬を提供すること。例文帳に追加

To obtain a prophylactic or therapeutic agent having safety and high efficacy by oral administration, against mitochondrial disease, especially chronic progressive external ophthalmoplegia syndrome(CPEO), MERRF(myoclonus epilepsy with ragged-red fiber), MELAS(mitochondrial encephalopathy, lactic acidosis and stroke) and diabetes, cardiomyopathy, Alzheimer's dementia, auditory difficulties, and retinal degenerative disease caused by mitochondrial genetic variation. - 特許庁

第十九条　使用者は、労働者が業務上負傷し、又は疾病にかかり療養のために休業する期間及びその後三十日間並びに産前産後の女性が第六十五条の規定によつて休業する期間及びその後三十日間は、解雇してはならない。ただし、使用者が、第八十一条の規定によつて打切補償を支払う場合又は天災事変その他やむを得ない事由のために事業の継続が不可能となつた場合においては、この限りでない。例文帳に追加

Article 19 (1) An employer shall not dismiss a worker during a period of absence from work for medical treatment with respect to injuries or illnesses suffered in the course of employment nor within 30 days thereafter, and shall not dismiss a woman during a period of absence from work before and after childbirth in accordance with the provisions of Article 65 nor within 30 days thereafter; provided, however, that this shall not apply in the event that the employer pays compensation for discontinuance in accordance with Article 81 nor when the continuance of the enterprise has been made impossible by a natural disaster or other unavoidable reason.  - 日本法令外国語訳データベースシステム

配列番号１で示されるアミノ酸配列と同一若しくは実質的に同一のアミノ酸配列、配列番号１に示されるアミノ酸配列の一部が欠損、置換または付加された組換え体のアミノ酸配列、前記アミノ酸配列の部分ペプチド、前記アミノ酸配列のフラグメント、または前記アミノ酸配列の塩のいずれか１つ以上を含有してなることを特徴とする止血疾患治療用の医薬組成物を提供する。例文帳に追加

This pharmaceutical composition for treating thrombotic diseases is characterized by containing one or more of an amino acid sequence identical or substantially identical to an amino acid sequence represented by sequence number 1, a recombinant amino acid sequence comprising the amino acid sequence which is partially deleted, replaced or added, a partial peptide of the amino acid sequence, a fragment of the amino acid sequence, and the salts of the amino acid sequence. - 特許庁

ラクトバチルス・デルブルエキイ、ラクトバチルス・アシドフィラス、ラクトバチルス・プランタラム、ラクトバチルス・ファーメンタム、ラクトバチルス・カゼイ、ラクトバチルス・ラムノーサス、ラクトコッカス・ラクティス及びストレプトコッカス・サーモフィラスからなる群から選ばれる３〜８種の乳酸菌とサッカロミセス・セレビシエとの混合培養物から得られる混合菌体及び／又は培養上清を含有する、炎症性疾患の改善用組成物。例文帳に追加

This composition for improving inflammatory diseases comprises a mixed bacterial cell and/or culture supernatant obtained from a mixed cultured product of three to eight kinds of lactic acid bacteria selected from the group consisting of Lactobacillus delbruckii, Lactobacillus acidophillus, Lactobacillus plantarum, Lactobacillus fermentum, Lactobacillus casei, Lactobacillus rhamnosus, Lactococcus lactis and Streptococcus thermophilus with Saccharomyces cerevisiae. - 特許庁

３　市町村は、第一項の申請があったときは、当該申請に係る被保険者の主治の医師に対し、当該被保険者の身体上又は精神上の障害の原因である疾病又は負傷の状況等につき意見を求めるものとする。ただし、当該被保険者に係る主治の医師がないときその他当該意見を求めることが困難なときは、市町村は、当該被保険者に対して、その指定する医師又は当該職員で医師であるものの診断を受けるべきことを命ずることができる。例文帳に追加

(3) A Municipality shall, when the application as prescribed in paragraph (1) is submitted, request an attending physician of the Insured Person pertaining to said application for opinions regarding the status of illness or injury that is the cause of the physical or mental problems of said Insured Person, however, provided that the Municipality may, when there is no attending physician of the Insured Person pertaining to said application, or it is difficult to request for said opinion, etc., order said Insured Person to obtain the diagnosis of a designated physician or from the Municipality's personnel who is a physician.  - 日本法令外国語訳データベースシステム

ここで、１つの実施形態において、糸球体腎炎は、巣状糸球体硬化症、虚脱糸球体症、最小変化疾病、半月体形成性糸球体腎炎、腎炎症候群、ネフローゼ症候群、原発性糸球体腎炎、続発性糸球体腎炎、増殖性糸球体腎炎、膜性糸球体腎炎、膜性増殖性糸球体腎炎、免疫複合体性糸球体腎炎、抗糸球体基底膜（抗ＧＢＭ）糸球体腎炎、少数−免疫性糸球体腎炎、糖尿病性糸球体腎炎、慢性糸球体腎炎および遺伝性腎炎からなる群より選択される。例文帳に追加

In one embodiment, the glomerulonephritis can be selected from the group consisting of focal glomeruloscerosis, collapsing glomerulopathies, minimal change disease, crescentic glomerulonephritis, nephritic syndrome, nephrotic syndrome, primary glomerulonephritis, secondary glomerulonephritis, proliferative glomerulonephritis, membraneous glomerulonephritis, membranoproliferative glomerulonephritis, immune-complex glomerulonephritis, anti-glomerular basement membrane (anti-GBM) glomerulonephritis, pauci-immune glomerulonephritis, diabetic glomerulopathy, chronic glomerulonephritis, and hereditary nephritis. - 特許庁

本発明の多くの実施形態において、本発明は、サイクリン依存性キナーゼインヒビターとしての新規な類型のピラゾロ［１，５−ａ］ピリミジン化合物、このような化合物の調製方法、１種以上のこのような化合物を含む医薬組成物、１種以上のこのような化合物を含む医薬製剤の調製方法、および、このような化合物または医薬組成物を用いたＣＤＫと関連する１種以上の疾患を処置、予防、抑止または改善する方法を提供する。例文帳に追加

The present invention relates to: a novel class of pyrazolo[1, 5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases; methods of preparing such compounds; pharmaceutical compositions comprising one or more such compounds; methods of preparing pharmaceutical formulations comprising one or more such compounds; and methods of treatment, prevention, inhibition or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions. - 特許庁

カルボキシメチル化された短鎖ジアルキルアミノアルキルアミドの形での両性イオン構造を有する非界面活性化合物、炎症性皮膚疾患などの治療薬としてのその使用、およびカルボン酸と短鎖ジアルキルアミノアルキルアミンより短鎖ジアルキルアミノアルキルアミドに転換した後、ハロゲンカルボン酸またはその塩で両性イオン構造を有する非界面活性化合物に転換する方法。例文帳に追加

This non-surfactant compound having an amphoteric ionic structure in a form of a carboxymethylated short chain dialkylaminoalkylamide, the use of the same as a treating agent of inflammatory skin diseases etc., and the method for converting a carboxylic acid and a short chain dialkylaminoalkylamine to a short chain dialkylaminoalkylamide and then converting to the non-surfactant having the amphoteric ionic structure by a halogenocarboxylic acid or its salt are provided. - 特許庁

免疫媒介及び炎症疾患に関連することが示されている新規インターロイキン-１７（ＩＬ-１７）のレセプター及び新規分泌ポリペプチドリガンド及びこれらペプチドをコードする核酸分子、これら核酸配列を含んでなるベクター及び宿主細胞、異種ポリペプチド配列に融合したポリペプチドを含んでなるキメラポリペプチド分子、ポリペプチドと結合する抗体、並びにポリペプチドを製造する方法である。例文帳に追加

A new interleukin-17(IL-17) receptor indicated to be associated with immune mediation and inflammatory diseases, a new secreted polypeptide ligand, nucleic acid molecules encoding these peptides, vectors and host cells containing these nucleic acid sequences, a chimeric polypeptide molecule including a polypeptide fused with a heterologous polypeptide sequence, an antibody bindable to the polypeptide, and a method for producing the polypeptide, are provided, respectively. - 特許庁

また、認知症または神経変性疾患を治療する医薬組成物および方法も開示されており、これは、式Ｉの化合物以外のβ−セクレターゼ阻害剤、ＨＭＧ−ＣｏＡレダクターゼ阻害剤、γ−セクレターゼ阻害剤、非ステロイド性抗炎症薬、Ｎ−メチル−Ｄ−アスパラギン酸塩レセプターアンタゴニスト、コリンエステラーゼ阻害剤または抗−アミロイド抗体と併用して、式Ｉの化合物を含有する。例文帳に追加

There are also disclosed pharmaceutical compositions and methods of treating dementia or neurodegenerative diseases comprising the compounds of the formula I in combination with a β-secretase inhibitor other than those of the formula I, an HMG-CoA reductase inhibitor, a γ-secretase inhibitor, a non-steroidal anti-inflammatory agent, an N-methyl-D-aspartate receptor antagonist, a cholinesterase inhibitor or an anti-amyloid antibody. - 特許庁

第十五条　都道府県知事又は市町村長は、家畜伝染病のまん延を防止するため緊急の必要があるときは、政令で定める手続に従い、七十二時間を超えない範囲内において期間を定め、牛疫、牛肺疫、口蹄疫又はアフリカ豚コレラの患畜又は疑似患畜の所在の場所（これに隣接して当該伝染性疾病の病原体により汚染し、又は汚染したおそれがある場所を含む。）とその他の場所との通行を制限し、又は遮断することができる。例文帳に追加

Article 15 Prefectural governors or mayors of municipalities may, when urgently necessary for preventing the spread of a domestic animal infectious disease, restrict or block passage between places where animals that have contracted or are suspected of having contracted rinderpest, contagious bovine pleuropneumonia, foot-and-mouth disease or African swine fever are located (including any neighboring location that is contaminated or likely to be contaminated with pathogens of said infectious disease) and other locations, specifying a time limit within a range not exceeding 72 hours, in accordance with procedures prescribed by Cabinet Order.  - 日本法令外国語訳データベースシステム

カプセル型内視鏡１で撮影した複数の画像を取得し、これらの画像が体内を撮影した前記画像か否かの判定をし、体内を撮影した画像と判定された画像を抽出し、その抽出した画像から実質的に同一か否かを判定し、別画像であると判定された画像を抽出し、さらに、疾患部位が撮影されている画像を抽出することができる画像処理装置７により、上記課題の解決を図る。例文帳に追加

This image processing apparatus 7 acquires a plurality of images taken by the capsule endoscope 1, determines whether or not the images are those picking up the body inside, extracts the images determined to be the images of the body inside, determines whether the images are substantially identical or not from the extracted images, extracts the images determined to be other images, and extracts the images picking up the affected portion. - 特許庁

BAZFからなる、ユビキチンリガーゼコンポーネント，BAZF及びCUL3からなる、ユビキチンリガーゼコンポーネント，当該コンポーネントを含むユビキチンリガーゼ，BAZFの発現を制御する物質を含むことを特徴とするユビキチンリガーゼ制御剤，又は、これらのコンポーネントやユビキチンリガーゼ，又はその制御剤のいずれかを含むことを特徴とする、Notchシグナル制御剤又はNotchシグナル伝達系の異常に起因する疾患の予防又は治療剤。例文帳に追加

There are disclosed: a ubiquitin ligase component comprising BAZF; a ubiquitin ligase component comprising BAZF and CUL3; a ubiquitin ligase including the components; a ubiquitin ligase controlling agent featured by including a substance for controlling the expression of BAZF; a Notch signal controlling agent featured by including any of these components, ubiquitin ligase and its controlling agents; or preventive or therapeutic agents for diseases caused by the abnormality of Notch signaling system. - 特許庁

1.天龍護念、2.善果日増、3.集聖上因、4.菩提不退、5.衣食豊足、6.疾疫不臨、7.離水火災、8.無盗賊厄、9.人見欽敬、10.神鬼助持、11.女転男身、12.為王臣女、13.端正相好、14.多生天上、15.或為帝王、16.宿智命通、17.有求皆従、18.眷属歓楽、19.諸横消滅、20.業道永除、21.去処盡通、22.夜夢安楽、23.先亡離苦、24.宿福受生、25.諸聖讃歎、26.聰明利根、27.饒慈愍心、28.畢竟成佛例文帳に追加

1. The Tenryu (protective deities) will guard and defend thee; 2. the fruits of goodness and virtue will shine increasingly on thee; 3. the wisdom of the sages shall accumulate within thee; 4. no retreat along the Bodhi path will be suffered by thee; 5. food, drink and clothing will not be lacking for thee; 6. disease and illness will not harm thee; 7. calamities of fire and water will not hurt thee; 8. thieves and robbers will not trouble thee; 9. respect from others will come to thee; 10. demonic spirits shall (even) aid thee; 11. from female to male transformed thou will become; 12. female minister to kings thou will become; 13. comely in appearance thou will be; 14. constant rebirth in deva heaven shall be accorded thee; 15. the role of monarch may fall unto thee; 16. wisdom from previous lives shall illuminate the future for thee; 17. all those who beseech thee shall follow thee; 18. a joyous and content family shall be granted thee; 19. chance, falsehood, and untrue doctrines shall cease to thwart thee; 20. eternal freedom from the karmic chain shall be thine; 21. no obstacles along any path shall obstruct thee; 22. peaceful and untroubled dreams will slumber bring thee; 23. thy ancestors who suffer from evil karma shall be liberated; 24. reborn shall they be, based on the good karma of thy past life; 25. praised by the sages thou will become; 26. intelligent and wise in nature thou will become; 27. rich in kindness and compassion thou will become; 28. enlightened thou will become.  - Wikipedia日英京都関連文書対訳コーパス

本条において，「医薬品」とは， (a) 何れかの物質又は物質の混合物で， (i) 人又は動物の疾病，不調，身体の異常状態又はこれらの兆候についての診断，治療，緩和又は予防，又は (ii) 人又は動物の有機的機能の回復，矯正若しくは修正， に使用するために製造，販売されるもの又は使用を表示されたもの，及び (b) (a)に記載する何れかの物質又は物質の混合物の調製又は製造に使用されている何れかの物質， を含むが，その物質又は物質の混合物であって，これまで食品医薬法に従って定められた規則により随時その表現に与えられた意味での専売薬と同一又は実質的に同一のものは含まない。例文帳に追加

In this section, “pharmaceutical preparation” includes (a) any substance or mixture of substances manufactured, sold or represented for use in (i) the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state, or the symptoms thereof, in humans or animals, or (ii) restoring, correcting or modifying organic functions in humans or animals, and (b) any substance to be used in the preparation or production of any substance or mixture of substances described in paragraph (a), but does not include any such substance or mixture of substances that is the same or substantially the same as a substance or mixture of substances that is a proprietary medicine within the meaning from time to time assigned to that expression by regulations made pursuant to the Food and Drugs Act.  - 特許庁

１６　この法律において「認知症対応型通所介護」とは、居宅要介護者であって、脳血管疾患、アルツハイマー病その他の要因に基づく脳の器質的な変化により日常生活に支障が生じる程度にまで記憶機能及びその他の認知機能が低下した状態（以下「認知症」という。）であるものについて、老人福祉法第五条の二第三項の厚生労働省令で定める施設又は同法第二十条の二の二に規定する老人デイサービスセンターに通わせ、当該施設において入浴、排せつ、食事等の介護その他の日常生活上の世話であって厚生労働省令で定めるもの及び機能訓練を行うことをいう。例文帳に追加

(16) The term "Outpatient Long-Term Care for a Dementia Patient" as used in this Act means to provide care for bathing, bodily waste elimination, meals, etc., and for other daily activities as determined by an Ordinance of the Ministry of Health, Labour, and Welfare, and functional training for an In-Home Person Requiring Long-Term Care who is in the condition that memory functions and other cognitive functions have become underactive as far as causing disorder with performing daily activities due to organic changes of the brain that are caused by cerebral vascular disease, Alzheimer's disease, or other factors (herein referred to as "Dementia"). This is accomplished by having said person commute to a facility as determined by an Ordinance of the Ministry of Health, Labour, and Welfare as set forth in Article 5-2, paragraph (3) of the Public Aid for the Aged Act or Long-Term Care Day Service Centers for the elderly as provided in Article 20-2-2 of the same Act.  - 日本法令外国語訳データベースシステム

２　外国人が十六歳に満たない場合又は疾病その他身体の故障により自ら申請若しくは登録証明書の受領若しくは提出をすることができない場合には、前項に規定する申請又は登録証明書の受領若しくは提出は、当該外国人と同居する次の各号に掲げる者（十六歳に満たない者を除く。）が、当該各号列記の順位により、当該外国人に代わつてしなければならない。外国人又は外国人であつた者が十六歳に満たない場合においては、第七条第七項又は第十二条第一項若しくは第二項の規定による登録証明書の返納についても、同様とする。例文帳に追加

(2) In cases where the alien is under the age of sixteen years or in cases where he/she is unable to make an application or perform the receipt or submission of the registration certificate in person by reason of illness or other physical impediments, the person specified in the following items and living with such alien (excluding any person under the age of sixteen years) in the order specified in the following items, shall make the application or perform the receipt or submission of the registration certificate provided for in the preceding paragraph on behalf of such person. In cases where the alien or the person who used to be an alien is under the age of sixteen years, the same shall apply to the return of the registration certificate under Article 7, paragraph (7) or Article 12, paragraph (1) or (2):  - 日本法令外国語訳データベースシステム

第十一条　機構は、被認定者が、その認定に係る指定疾病につき、健康保険法（大正十一年法律第七十号）第六十三条第三項第一号に規定する保険医療機関又は保険薬局その他病院、診療所（これらに準ずるものを含む。）又は薬局であって環境省令で定めるもの（これらの開設者が診療報酬の請求及び支払に関し第十三条第一項に規定する方式によらない旨を機構に申し出たものを除く。以下「保険医療機関等」という。）から次に掲げる医療を受けたときは、当該被認定者に対し、その請求に基づき、医療費を支給する。この場合において、被認定者が第五条第一項の決定に係る死亡した者以外の者であるときは、当該被認定者が石綿健康被害医療手帳を提示して医療を受けたときに限り、医療費を支給するものとする。例文帳に追加

Article 11 When a certified person has received any of the following medical services for the designated disease to which the certification pertains from an authorized insurance medical institution or insurance pharmacy, hospital or clinic respectively prescribed in Item 1, Paragraph 3, Article 63 of the Health Insurance Act (Act No. 70 of 1922) (including an equivalent of any of the foregoing) or a pharmacy prescribed in an Ordinance of the Ministry of the Environment (excluding any of the foregoing medical institutions, etc. whose founder has declared to the Agency to the effect that its billing and payment of medical fees will not comply with the system prescribed in Paragraph 1, Article 13)( hereinafter referred to as "authorized insurance medical institution, etc."), the Agency, based upon the request of said certified person, shall pay medical expenses for said certified person. In such case, in the event that the certified person is other than the deceased person to which the decision in Paragraph 1, Article 5 pertains, medical expenses shall be paid only when the concerned certified person has received medical services after having presented his/her Asbestos Health Damage Medical Passbook.  - 日本法令外国語訳データベースシステム

通信手段を介して患者用端末と医師用端末とが接続されて構成され、少なくとも、スクリーニング情報及び問診情報を記憶する記憶部と、スクリーニング情報及び問診情報を表示する情報表示部と、スクリーニング情報及び問診情報に対する回答を入力する入力部と、入力された回答に基づき、記憶部から問診情報を読み出し情報表示部に表示させる制御部と、入力部から入力された回答に基づき診断を行う診断部と、診断部による診断結果を表示する診断結果表示部とを具備する問診システムを構築し、患者用端末にスクリーニング情報及び問診情報を表示し、患者自身が端末を操作して回答した内容に基づいて疾患を推定する。例文帳に追加

The screening information and the medical inquiry are displayed on the patient terminal and the patient himself/herself operates the terminal and estimates the disease based on the contents of the answer. - 特許庁

第一条　この法律は、加齢に伴って生ずる心身の変化に起因する疾病等により要介護状態となり、入浴、排せつ、食事等の介護、機能訓練並びに看護及び療養上の管理その他の医療を要する者等について、これらの者が尊厳を保持し、その有する能力に応じ自立した日常生活を営むことができるよう、必要な保健医療サービス及び福祉サービスに係る給付を行うため、国民の共同連帯の理念に基づき介護保険制度を設け、その行う保険給付等に関して必要な事項を定め、もって国民の保健医療の向上及び福祉の増進を図ることを目的とする。例文帳に追加

Article 1 The purposes of this Act are to improve health and medical care and to enhance the welfare of citizens. With regard to people who are under condition of need for long-term care due to disease, etc., as a result of physical or emotional changes caused by aging, and who require care such as for bathing, bodily waste elimination, meals, etc., and require the functional training, nursing, management of medical treatment, and other medical care, these purposes are to be accomplished by establishing a long-term care insurance system based on the principle of the cooperation of citizens, solidarity, and determining necessary matters concerning related insurance benefits, etc., in order to provide benefits pertaining to necessary health and medical services and public aid services so that these people are able to maintain dignity and an independent daily life routine according to each person's own level of abilities.  - 日本法令外国語訳データベースシステム

食品（野菜、果物、菓子、調理品等その外観、形状等から明らかに食品と認識される物、及び健康増進法第２６条の規定に基づき許可を受けた用途を表示する特別用途食品を除く）の広告に医薬品のような効用効能（人または動物の疾病の診断、治療または予防、及び人または動物の身体の構造または機能に影響を及ぼすこと）を標榜し、これにより当該食品が医薬品に該当するとみなされた場合には、その広告は薬事法第６８条違反となり、同法第８５条により２年以下の懲役または２００万円以下の罰金により処罰される。例文帳に追加

If the advertisements of food indicate any medical efficacy such as diagnosis, prevention or curing of human or animal diseases, or effects on the structure and function of human beings or animals, such food may be deemed as an unauthorized drug, in which case such advertisement will constitute a violation of Article 68 of the Pharmaceutical Affairs Law, which provides for imprisonment of up to two (2) years or a fine of up to two million (2,000,000) yen. (As stated, Article 68 does not apply to foods like vegetables, fruits, sweets and prepared foods, etc., which are undoubtedly recognized as food by their appearance or form, etc., or to food for special dietary use containing indications of the specified usage, as authorized under of Article 26 of the Health Promotion Law.)  - 経済産業省

４． 発生前の段階からの情報収集・情報提供体制の構築や収集した情報の公開、発生時の対応を一層強化することが必要であり、このため、厚生労働省のみならず、国立感染症研究所（感染症情報センターやインフルエンザウイルス研究センターを中心に）や、検疫所などの機関、地方自治体の保健所や地方衛生研究所を含めた感染症対策に関わる危機管理を専門に担う組織や人員体制の大幅な強化、人材の育成を進めるとともに、関係機関のあり方や相互の役割分担、関係の明確化等が必要である。特に国立感染症研究所については、米国ＣＤＣ（疾病予防管理センター）を始め各国の感染症を担当する機関を参考にして、より良い組織や人員体制を構築すべきである。例文帳に追加

4. It is necessary to further strengthen countermeasures at the onset of an outbreak, and to develop a system to collect/ provide /communicate/disclose information in the pre-pandemic phase. For this purpose, it is essential to strengthen the institutional capacity and human resources of the Ministry and the National Institute of Infectious Diseases (NIID; the Infectious Diseases Surveillance Center and the Influenza Virus Research Center, in particular), quarantine stations, public health centers and prefectural/city institutes of public health (hereafter, the Institutes). The government needs to significantly improve risk management skills specialized in infectious diseases through strengthening staff structures and individual capacities at these institutions. It is also necessary to determine future roles and the division of labor to clarify relationships among relevant institutions and organizations mentioned above. Particularly, the NIID should be better organized and staffed by reference to the US Centers for Disease Control (US-CDC) and other international organizations in charge of infectious diseases. - 厚生労働省

第三十六条の三　第二十五条第二項（第三十六条第七項において準用する場合を含む。）又は第二十九条第五項（第三十条の二及び第三十六条第七項において準用する場合を含む。）の規定により、消火若しくは延焼の防止若しくは人命の救助その他の消防作業に従事した者又は第三十五条の七第一項の規定により市町村が行う救急業務に協力した者が、そのため死亡し、負傷し、若しくは疾病にかかり又は障害の状態となつた場合においては、市町村は、政令で定める基準に従い条例の定めるところにより、その者又はその者の遺族がこれらの原因によつて受ける損害を補償しなければならない。例文帳に追加

Article 36-3 (1) Where a person who has been engaged in carrying out the activities for extinguishing a fire or preventing the spread of a fire or to rescue human life and other firefighting activities pursuant to the provisions of Article 25, paragraph (2) (including cases where applied mutatis mutandis pursuant to Article 36, paragraph (7)) or Article 29, paragraph (5) (including cases where applied mutatis mutandis pursuant to Article 30-2 and Article 36, paragraph (7)) or a person who has cooperated with the ambulance services provided by a municipality pursuant to the provision of Article 35-7, paragraph (1), has died, suffered an injury or contracted a disease, or become disabled, the municipality shall, as provided for by municipal ordinance in accordance with the standards specified by Cabinet Order, compensate for any damage suffered by such person or his/her surviving family due to such engagement or cooperation.  - 日本法令外国語訳データベースシステム

第二百二条　留置業務管理者は、負傷し、又は疾病にかかっている被留置者が、当該留置業務管理者が委嘱する医師等以外の医師等を指名して、その診療を受けることを申請した場合において、傷病の種類及び程度、留置施設に留置される前にその医師等による診療を受けていたことその他の事情に照らして、その被留置者の医療上適当であると認めるときは、内閣府令で定めるところにより、留置施設内又は留置業務管理者が適当と認める病院若しくは診療所において、自弁によりその診療を受けることを許すことができる。例文帳に追加

Article 202 (1) In cases where a detainee sustaining an injury or suffering from a disease claims to designate a doctor who is not commissioned by the detention services manager to receive a medical treatment, if such claim is deemed appropriate for the detainee's medical care in light of such circumstances as the type and degree of the injury or disease, and as the fact that the detainee had been visiting said doctor on the regular basis for medical treatments prior to the detention in the detention facility, then the detention services manager may, pursuant to a Cabinet Office Ordinance, permit the detainee to receive the medical treatment inside the detention facility or in a hospital or a clinic which the detention services manager recognizes as to be appropriate at his/her own expenses.  - 日本法令外国語訳データベースシステム

例えば、該組合せが、(a) 主作用が同じである公知の成分同士の組合せ、(b) 公知の主成分の効能に係る問題を解消することができる公知の副成分との組合せ (例えば、副作用を有することが公知の主成分と、その副作用を減弱させることができる公知の副成分との組合せ )、(c)主疾病から生じる種々の症状のそれぞれに治療効果を有することが公知の成分の組合せ、等の場合には、引用発明に基づいて、当業者が請求項に係る医薬発明を容易に想到し得たものであることを論理づけできる場合が多く、通常、請求項に係る医薬発明の進歩性は否定される (事例 8～11)。例文帳に追加

For example, if the pertinent combination corresponds to the followings, in most cases, it is reasoned that a person skilled in the art would have easily arrived at the claimed medicinal invention and the inventive step is usually denied (Example 8 to 11): (a) combination of publicly known components of which major effects are the same, (b) combination of a major component having a publicly known problems related to the efficacy thereof with a subordinate component having publicly known ability to eliminate the problem (for example, in case of the combination of the major component having a publicly known side effect and a subordinate component having a publicly known ability of reducing the side effect), and (c) combination of publicly known components having respective curative effects for a variety of symptoms arising from a major disease, and the like.  - 特許庁

３　国有林野事業を行う国の経営する企業に勤務する職員の給与等に関する特例法（昭和二十九年法律第百四十一号。以下この条において「給特法」という。）の適用を受ける国家公務員（国家公務員法（昭和二十二年法律第百二十号）第八十一条の五第一項に規定する短時間勤務の官職を占める者以外の常時勤務することを要しない国家公務員を除く。以下この条において同じ。）は、給特法第四条に規定する農林水産大臣又は政令の定めるところによりその委任を受けた者（以下「農林水産大臣等」という。）の承認を受けて、当該国家公務員の配偶者、父母、子又は配偶者の父母であって負傷、疾病又は身体上若しくは精神上の障害により第二条第三号の厚生労働省令で定める期間にわたり日常生活を営むのに支障があるもの（以下この条において「要介護家族」という。）の介護をするため、休業をすることができる。例文帳に追加

(3) A national public officer who is subject to the Special Act on Wages, etc. of Personnel Working in National Enterprises Managing National Forest (Act No. 141 of 1954; referred to as "Special Wage Act" hereinafter in this Article) (excluding a national public officer who is not required to work full-time or does not hold an official post with part-time working hours prescribed in Article 81-5 paragraph 1 of the National Public Service Act (Act No. 120 of 1947), the same shall apply in this Article) may, upon obtaining an approval of the Minister of Agriculture, Forestry and Fisheries or a person to whom the Minister, pursuant to the provisions of a Cabinet Order, delegates the authority prescribed in Article 4 of the Special Wage Act (hereinafter referred to as "the Minister of Agriculture, Forestry and Fisheries, etc."), take leave in order to take care of a person who is a spouse, a parent, a child, or a parent of a spouse of said national public officer and who, due to injury, sickness, or physical or mental disability, has difficulty in leading his/her daily life for a period specified by Ordinance of the Ministry of Health, Labour and Welfare provided for in Article 2 item (iii) (referred to as a "Family Member in Care-requiring Condition" hereinafter in this Article).  - 日本法令外国語訳データベースシステム

第七条　昭和五十五年十二月三十一日において、労働保険の保険料の徴収等に関する法律（以下「徴収等」という。）第三条に規定する労災保険に係る労働保険の保険関係が成立している事業に関する第二条の規定による改正後の徴収法第十二条第三項の規定の適用については、同項中「遺族補償一時金」とあるのは「遺族補償一時金（昭和五十五年十二月三十一日後に支給すべき事由が生じたものに限る。）」と、「（以下この項及び第二十条第一項において「特定疾病にかかつた者に係る保険給付」という。）」とあるのは「（以下この項において「特定疾病にかかつた者に係る保険給付」といい、同日後の期間に係る年金たる保険給付及び同日後に支給すべき事由が生じた年金たる保険給付以外の保険給付に限る。）」と、「乗じて得た額」とあるのは「乗じて得た額（一般保険料又は第一種特別加入保険料の額の算定の基礎となつた期間のうちに同日以前の期間がある場合には、同日以前の期間に係る一般保険料の額から通勤災害に係る率に応ずる部分の額を減じた額と第一種特別加入保険料の額から通勤災害に係る率に応ずる部分の額を減じた額とを合算した額に同日後の期間に係る一般保険料の額から通勤災害に係る率に応ずる部分の額を減じた額と第一種特別加入保険料の額から通勤災害に係る率に応ずる部分の額を減じた額とを合算した額に調整率を乗じて得た額を加えた額）」と、「同日を」とあるのは「十二月三十一日を」とする。例文帳に追加

Article 7 (1) With regard to the application of the provision of Article 12, paragraph (3) of the Act on Collection, etc. of Insurance Premiums of Labor Insurance (hereinafter referred to as the "Collection Act") as revised by the provision of Article 2 to the businesses in respect of which the insurance relation of labor insurance pertaining to the industrial accident insurance prescribed by Article 3 of the Collection Act has been established as of December 31, 1980, the term "the lump sum compensation for surviving family" in the same paragraph shall be deemed to be replaced with "the lump sum compensation for surviving family (limited to the case where the cause for such payment occurs after December 31, 1980)", the term "(hereinafter referred to as the "insurance benefits pertaining to persons afflicted with a specific disease" in this paragraph and in Article 20, paragraph (1))" with "(hereinafter referred to as the "insurance benefits pertaining to persons afflicted with a specific disease" in this paragraph; limited to the insurance benefits other than the insurance benefits paid as pension pertaining to the period after the same date and the insurance benefits paid as pension the cause for payment of which occurs after the same date)", the term "the amount obtained by multiplying...referred to as the "Class I adjustment rate")" with "the amount obtained by multiplying ...referred to as the "Class I adjustment rate") (or, if any period on or before the same date exists during the period being the basis of calculation of the general insurance premiums or the Class I special enrollment insurance premiums, the aggregate of the amount of the general insurance premiums after deducting the amount of the portion corresponding to the rate pertaining to commuting injury and the amount of the Class I special enrollment insurance premiums after deducting the amount of the portion corresponding to the rate pertaining to commuting injury, both pertaining to the period on or before the same date, plus the amount obtained by multiplying the aggregate of the amount of the general insurance premiums after deducting the amount of the portion corresponding to the rate pertaining to commuting injury and the amount of the Class I special enrollment insurance premiums after deducting the amount of the portion corresponding to the rate pertaining to commuting injury, both pertaining to the period after the same date, by the adjustment rate)", and the term "the same date" with "December 31".  - 日本法令外国語訳データベースシステム

一　事業が終了した日から三箇月を経過した日前における労災保険法の規定による業務災害に関する保険給付（労災保険法第十六条の六第一項第二号の場合に支給される遺族補償一時金及び特定疾病にかかつた者に係る保険給付を除く。）の額に第十二条第三項の厚生労働省令で定める給付金の額を加えた額と一般保険料に係る確定保険料の額（同条第一項第一号の事業については、労災保険率に応ずる部分の額。次号において同じ。）から非業務災害率に応ずる部分の額を減じた額に第一種特別加入保険料に係る確定保険料の額から特別加入非業務災害率に応ずる部分の額を減じた額を加えた額に第一種調整率を乗じて得た額との割合が百分の八十五を超え、又は百分の七十五以下であつて、その割合がその日以後において変動せず、又は厚生労働省令で定める範囲を超えて変動しないと認められるとき。例文帳に追加

(i) If the ratio between the amount of the insurance benefits concerning employment injury provided for in the Industrial Accident Insurance Act (excluding the lump sum compensation for surviving family paid in case of Article 16-6, paragraph (1), item (ii) of the Industrial Accident Insurance Act and the insurance benefits pertaining to persons afflicted with a specific disease) prior to the day on which three months have elapsed from the day the business is terminated, plus the amount of the benefits specified by the Ordinance of the Ministry of Health, Labour and Welfare set forth in Article 12, paragraph (3) on one hand, and the amount of final insurance premiums pertaining to the general insurance premiums (or, in case of the businesses set forth in the same Article, paragraph (1), item (i), the amount of the portion corresponding to the industrial accident insurance rate; the same shall apply in the following item) after deducting the amount of the portion corresponding to the off-the-job injury rate, plus the amount of final insurance premiums pertaining to the Class I special enrollment insurance premiums after deducting the amount of the portion corresponding to the special enrollment off-the-job injury rate, multiplied by the Class I adjustment rate on the other hand, exceeds eighty-five one-hundredth (85/100), or is seventy-five one-hundredth (75/100) or less, and such ratio does not change on and after such date, or such ratio is deemed as not changing beyond the scope specified by the Ordinance of the Ministry of Health, Labour and Welfare; or  - 日本法令外国語訳データベースシステム

２　獣畜及び家きんの肉及び臓器並びに厚生労働省令で定めるこれらの製品（以下この項において「獣畜の肉等」という。）は、輸出国の政府機関によつて発行され、かつ、前項各号に掲げる疾病にかかり、若しくはその疑いがあり、同項各号に掲げる異常があり、又はへい死した獣畜又は家きんの肉若しくは臓器又はこれらの製品でない旨その他厚生労働省令で定める事項（以下この項において「衛生事項」という。）を記載した証明書又はその写しを添付したものでなければ、これを食品として販売の用に供するために輸入してはならない。ただし、厚生労働省令で定める国から輸入する獣畜の肉等であつて、当該獣畜の肉等に係る衛生事項が当該国の政府機関から電気通信回線を通じて、厚生労働省の使用に係る電子計算機（入出力装置を含む。）に送信され、当該電子計算機に備えられたファイルに記録されたものについては、この限りでない。例文帳に追加

(2) The meat and organs of livestock and poultry and products thereof specified by an Ordinance of the Ministry of Health, Labour and Welfare (hereinafter referred to as "livestock meat, etc." in this paragraph) shall not be imported as food for the purpose of marketing, unless they have certificates attached which have been issued by a governmental organization of an exporting country, and which certify that they are not the meat or organs of livestock and poultry or products thereof which have or are suspected to have any of the diseases listed in each item of the preceding paragraph, have any of the disorders listed in each item of the same paragraph, or have died, and which contain other matters specified by an Ordinance of the Ministry of Health, Labour and Welfare (hereinafter referred to as "matters regarding sanitation" in this paragraph); provided, however, that this shall not apply to livestock meat, etc. imported from countries specified by an Ordinance of the Ministry of Health, Labour and Welfare, for which matters regarding sanitation concerning said livestock meat, etc. have been sent from a governmental organization of said countries via a telecommunications line to a computer (with an input-output device) used by the Ministry of Health, Labour and Welfare and has been recorded in a file on said computer.  - 日本法令外国語訳データベースシステム

同一の事由（障害補償年金及び遺族補償年金については、それぞれ、当該障害又は死亡をいい、傷病補償年金については、当該負傷又は疾病により障害の状態にあることをいう。以下同じ。）により、障害補償年金若しくは傷病補償年金又は遺族補償年金と厚生年金保険法の規定による障害厚生年金及び国民年金法の規定による障害基礎年金（同法第三十条の四の規定による障害基礎年金を除く。以下同じ。）又は厚生年金保険法の規定による遺族厚生年金及び国民年金法の規定による遺族基礎年金若しくは寡婦年金とが支給される場合にあつては、下欄の額に、次のイからハまでに掲げる年金たる保険給付の区分に応じ、それぞれイからハまでに掲げるところにより算定して得た率を下らない範囲内で政令で定める率を乗じて得た額（その額が政令で定める額を下回る場合には、当該政令で定める額）例文帳に追加

In cases where a disability compensation pension, injury and disease compensation pension or compensation pension for surviving family is paid, and on the same grounds (meaning the relevant disability or death in the case of a disability compensation pension and compensation pension for surviving family, and the fact of being disabled due to the relevant injury or disease in the case of an injury and disease compensation pension, respectively; the same shall apply hereinafter), a disability employee's pension under the provisions of the Employee's Pension Insurance Act and a basic pension for surviving family under the provisions of the National Pension Act (excluding a disability basic pension under the provision of Article 30-4 of the National Pension Act; the same shall apply hereinafter) or an employee's pension for surviving family under the provisions of the Employee's Pension Insurance Act and a basic pension for surviving family or widow's pension under the provisions of the National Pension Act are also paid: the amount obtained by multiplying each of the amounts listed in the lower columns by the rate specified by a Cabinet Order within a range not lower than the rate obtained by making the calculation as explained in (a) to (c) below according to the categories of insurance benefits in pension form listed in (a) to (c) respectively (if the amount thus obtained is less than the amount specified by a Cabinet Order, said amount specified by a Cabinet Order)  - 日本法令外国語訳データベースシステム

３　厚生労働大臣は、連続する三保険年度中の各保険年度において次の各号のいずれかに該当する事業であつて当該連続する三保険年度中の最後の保険年度に属する三月三十一日（以下この項において「基準日」という。）において労災保険に係る保険関係が成立した後三年以上経過したものについての当該連続する三保険年度の間における労災保険法の規定による業務災害に関する保険給付（労災保険法第十六条の六第一項第二号の場合に支給される遺族補償一時金、特定の業務に長期間従事することにより発生する疾病であつて厚生労働省令で定めるものにかかつた者（厚生労働省令で定める事業の種類ごとに、当該事業における就労期間等を考慮して厚生労働省令で定める者に限る。）に係る保険給付（以下この項及び第二十条第一項において「特定疾病にかかつた者に係る保険給付」という。）及び労災保険法第三十六条第一項の規定により保険給付を受けることができることとされた者（以下「第三種特別加入者」という。）に係る保険給付を除く。）の額（年金たる保険給付その他厚生労働省令で定める保険給付については、その額は、厚生労働省令で定めるところにより算定するものとする。第二十条第一項において同じ。）に労災保険法第二十九条第一項第二号に掲げる事業として支給が行われた給付金のうち業務災害に係るもので厚生労働省令で定めるものの額（一時金として支給された給付金以外のものについては、その額は、厚生労働省令で定めるところにより算定するものとする。）を加えた額と一般保険料の額（第一項第一号の事業については、前項の規定による労災保険率（その率がこの項の規定により引き上げ又は引き下げられたときは、その引き上げ又は引き下げられた率）に応ずる部分の額）から非業務災害率（労災保険法の適用を受けるすべての事業の過去三年間の通勤災害に係る災害率及び二次健康診断等給付に要した費用の額その他の事情を考慮して厚生労働大臣の定める率をいう。以下この項及び第二十条第一項において同じ。）に応ずる部分の額を減じた額に第一種特別加入保険料の額から特別加入非業務災害率（非業務災害率から第十三条の厚生労働大臣の定める率を減じた率をいう。第二十条第一項各号及び第二項において同じ。）に応ずる部分の額を減じた額を加えた額に業務災害に関する年金たる保険給付に要する費用、特定疾病にかかつた者に係る保険給付に要する費用その他の事情を考慮して厚生労働省令で定める率（第二十条第一項第一号において「第一種調整率」という。）を乗じて得た額との割合が百分の八十五を超え、又は百分の七十五以下である場合には、当該事業についての前項の規定による労災保険率から非業務災害率を減じた率を百分の四十の範囲内において厚生労働省令で定める率だけ引き上げ又は引き下げた率に非業務災害率を加えた率を、当該事業についての基準日の属する保険年度の次の次の保険年度の労災保険率とすることができる。例文帳に追加

(3) If the ratio between the amount of the insurance benefits pertaining to employment injury provided for in the Industrial Accident Insurance Act (excluding the lump sum compensation for surviving family paid in case of Article 16-6, paragraph (1), item (ii) of the Industrial Accident Insurance Act, the insurance benefits pertaining to persons afflicted with a disease caused as a result of having been engaged in a specific job or occupation for a long period which is specified by the Ordinance of the Ministry of Health, Labour and Welfare (limited to the persons specified by the Ordinance of the Ministry of Health, Labour and Welfare for each type of the businesses specified by the Ordinance of the Ministry of Health, Labour and Welfare, taking into consideration of the service period in respect of such business, etc.) (hereinafter referred to as the "insurance benefits pertaining to persons afflicted with a specific disease" in this paragraph and in Article 20, paragraph (1)), and the insurance benefits pertaining to persons deemed as entitled to receive the insurance benefit pursuant to the provision of Article 36, paragraph (1) of the Industrial Accident Insurance Act (hereinafter referred to as the "insured of Class III special enrollment")) in respect of any business falling under any of the following items during each insurance year of three consecutive insurance years and in respect of which business three years or more have passed, since the establishment of the insurance relation of industrial accident insurance, as of March 31 of the last insurance year of such consecutive three insurance years (hereinafter referred to as the "reference date" in this paragraph), the payment of which has been made during such consecutive three insurance years (or, in case of insurance benefits paid as pension or otherwise specified by the Ordinance of the Ministry of Health, Labour and Welfare, the amount thereof shall be calculated pursuant to the provisions of the Ordinance of the Ministry of Health, Labour and Welfare; the same shall apply in Article 20, paragraph (1)), plus the amount of the payments made as the services listed in Article 29, paragraph (1), item (ii) of the Industrial Accident Insurance Act which pertain to employment injury and which are specified by the Ordinance of the Ministry of Health, Labour and Welfare (or, in case of payments other than those paid as lump sum payments, the amount thereof shall be calculated pursuant to the provisions of the Ordinance of the Ministry of Health, Labour and Welfare) on one hand, and the amount obtained by multiplying the aggregate of the amount of the general insurance premiums (or, in case of the businesses set forth in paragraph (1), item (i), the amount of the portion corresponding to the industrial accident insurance rate prescribed in the preceding paragraph (or, if such rate has been increased or decreased pursuant to the provision of such paragraph, such increased or decreased rate)) after deducting the amount of the portion corresponding to the off-the-job injury rate (meaning the rate prescribed by the Minister of Health, Labour and Welfare by taking into consideration of the injury rate pertaining to commuting injury and the amount of the costs required for the benefit for second medical examination, etc. during the past three years in respect of all businesses to which the Industrial Accident Insurance Act is applied, and other circumstances; hereinafter the same shall apply in this paragraph and in Article 20, paragraph (1)) plus the amount of the Class I special enrollment insurance premiums after deducting the amount of the portion corresponding to the special enrollment off-the-job injury rate (meaning the off-the-job injury rate after deducting the rate determined by the Minister of Health, Labour and Welfare set forth in Article 13; the same shall apply in each item of Article 20, paragraph (1) and in Article 20, paragraph (2)), by the rate specified by the Ordinance of the Ministry of Health, Labour and Welfare by taking into consideration of the costs required for the insurance benefits paid as pension concerning employment injury, the costs required for the insurance benefits pertaining to persons afflicted with a specific disease, and other circumstances (in Article 20, paragraph (1), item (i) referred to as the "Class I adjustment rate") on the other hand, exceeds eighty-five one-hundredth (85/100), or is seventy-five one-hundredth (75/100) or less, then the Minister of Health, Labour and Welfare may acknowledge the rate calculated by increasing or decreasing the industrial accident insurance rate prescribed in the preceding paragraph in respect of such business less the off-the-job injury rate, by the rate specified by the Ordinance of the Ministry of Health, Labour and Welfare within the scope of forty one-hundredth (40/100), as the industrial accident insurance rate for the insurance year two years following the insurance year in which the reference date of such business is included.  - 日本法令外国語訳データベースシステム